|Horizon||30 Days Login to change|
Kappac Pharma Total Value AnalysisKappac Pharma Ltd is now anticipated to have takeover price of 3.17 B with market capitalization of 3.41 B, debt of 4.96 M, and cash on hands of 243.84 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Kappac Pharma fundamentals before making investing decisions based on the enterprise value of the company
Kappac Pharma Asset UtilizationKappac Pharma Ltd secures negative usage of assets of -0.13 %, making only 0.0 for each of assets held by the firm. Inadequate assets utilization conveys that the company is being less effective with each of assets it secures. Strictly speaking assets utilization of Kappac Pharma Ltd shows how discouraging it operates for each spent on its assets.
Kappac Pharma Profitability AnalysisThe company reported revenue of . Net Loss for the year was (786 K).